ACN Newswire

Fri Feb 12

Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China

Written by ACN Newswire

FOSTER CITY, Calif. and HANGZHOU, China and HOUSTON, Texas, Feb 11, 2021 - (ACN Newswire) - Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, and Iterion Therapeutics, Inc., a venture-backed, clinical stage biotechnology company developing novel...

ACN Newswire

Apollomics, Inc. and Iterion Therapeutics Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Tegavivint in Greater China

Tassie devils' decline has left a feast of carrion for feral cats

Environmental destruction is a war crime, but it's almost impossible to fall foul of the laws

Malcolm Turnbull Statement – Paris terrorist attack

Putin for life? Many Russians may desire leadership change, but don't see a viable alternative

What to Look Out for When Buying Opals

The Great Barrier Reef outlook is 'very poor'. We have one last chance to save it

FactCheck: do 'over a million' people in Australia not speak English 'well or at all'?

The elephant in the planning scheme: how cities still work around the dominance of parking space

Eurovision shock: is ironic appreciation now unnecessary as slick singing styles reign?

Choosing The Best Auxiliary Lighting for Your Motorcycle

Cutting unemployment will require an extra $70 to $90 billion in stimulus. Here’s why